Related Experiment Videos

[Prophylactic thyroidectomy in carriers of RET oncogene mutation carriers]

J Høie1, K Heimdal, J M Nesland

  • 1Avdeling for kirurgisk onkologi, Det Norske Radiumhospital, 0310 Oslo. johanhoi@online.no

Abstract

Insights

Genetic testing for medullary thyroid cancer (MTC) is reliable. Prophylactic thyroidectomy is recommended for gene carriers by age six to prevent MTC development.

Area of Science:

  • Endocrinology
  • Oncology
  • Genetics

Context:

  • Medullary thyroid cancer (MTC) is an inherited endocrine neoplasm.
  • Germline mutations in the RET oncogene are associated with Multiple Endocrine Neoplasia type 2 (MEN2).
  • Early thyroidectomy is recommended for mutation carriers.

Purpose:

  • To evaluate the outcomes of prophylactic thyroidectomy in children with germline RET mutations.
  • To assess the reliability of genetic diagnostics for familial MTC.
  • To determine the optimal age for intervention.

Summary:

  • Four children with germline RET mutations underwent thyroidectomy.
  • Post-surgery, one developed minimal MTC with lymph node metastases; others showed C-cell hyperplasia.
  • Genetic testing confirmed mutation status, preventing unnecessary surgeries in some relatives.

Impact:

  • Genetic diagnostic testing is a safe and reliable predictive tool for familial MTC.
  • Prophylactic thyroidectomy in gene carriers by age six is advised.
  • This approach allows for precise intervention, improving patient outcomes and avoiding unnecessary procedures.

Related Concept Videos